The Bioequivalence Of Two Different Lurasidone Formulations In Patients
Clinical trial NCT01082250 · COMPLETED
Trial details
- NCT number
- NCT01082250
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2008-09-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.